Nodular melanoma is a fast-growing, aggressive form of skin cancer that can grow into the deeper layers of the skin quickly if not removed. It is the second most common kind of melanoma. Even so, ...

October 15, 2012 (Atlanta, Georgia) — Routine imaging is unreliable for the staging and surveillance of patients with malignant melanoma who are asymptomatic for metastases, according to a literature ...

A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the Department of Surgery at the University of Utah (the U), is testing a new ...

The U.S. Food and Drug Administration (FDA) has approved a new type of cell-based therapy for people with advanced melanoma, and it may one day open up new treatment options for people with a wide ...

Jennifer Frederick was in the best shape of her life in 2023, so when she felt a small lump in her groin area after a week of workouts. She thought it was just a pulled muscle, but a month later, the ...

Malignant melanoma is a type of skin cancer that originates in melanocytes. Although these pigment-producing cells are found primarily in the basal layer of the skin, they are also located in the GI ...

IBI363, a bispecific antibody, targets PD-1 and enhances IL-2, improving T cell function in melanoma treatment. The FDA's fast track designation aims to expedite IBI363's development and approval for ...

In July, the FDA issued a complete response letter (CRL) for Replimune's biologics license application for RP1 (vusolimogene ...

Cylembio combined with Keytruda improved progression-free survival in advanced melanoma, achieving 19.4 months versus 11.0 months with Keytruda alone. PD-L1 negative patients showed significant ...

First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...